Senior/Principal Scientist, MPN Biology, Translational Sciences
Core
Lead the design, execution, and interpretation of cell-based, in vivo pharmacology, translational biomarker, and mechanism of action studies to drive novel myeloproliferative neoplasm (MPN) therapeutics from discovery to first-in-human clinical trials.
Role type
Senior/Principal Scientist, MPN Biology, Translational Sciences
Builds
First-in-class and best-in-class therapeutics including cytokines, antibodies, antibody-drug-conjugates, cell-based therapies, and small molecules for MPNs.
Domain
Biopharmaceuticals, Hematology, Oncology, Immunology
Required skills
MPN stem cell biology, driver mutation signaling pathways, in vivo MPN mouse models, biomarker discovery, drug development strategy, regulatory submission support, scientific leadership, cross-functional collaboration
Preferred skills
Hematological malignancies expertise, clinical trial design/operations, pharmacokinetic/pharmacodynamic software proficiency, academic collaboration experience
Technologies
NONMEM, Phoenix WinNonlin, R
Responsibilities
Lead design and execution of POC and translational studies in healthy and MPN mouse models and primary human cellular systems; Conduct translational studies to maximize clinical potential of marketed drug BESREMI; Oversee analysis and interpretation of in vitro and in vivo pharmacology/translational biomarker data; Contribute to development of clinical pharmacology strategies for investigational drugs; Work with regulatory affairs to support preparation of IND, NDA, and MAA submissions; Provide scientific leadership and mentorship to junior scientists and project teams
Seniority
Senior/Principal, hands-on IC with leadership responsibilities